GSK and other drugmakers on Monday asked a Delaware court for permission to appeal a ruling allowing more than 70,000 ...
A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case ...
GSK said in a statement that it did not settle with the woman ... More than 72,000 lawsuits remain pending over Zantac against companies that sold the drug, which also include Pfizer and Sanofi.
The London-based pharmaceutical manufacturer noted the plaintiff's voluntary dismissal of the Zantac case, Kasza, which was scheduled to start trial in Illinois state court. GSK said it did not settle ...
A federal judge has approved Novant Health Inc.'s $6.6 million settlement of a class-action lawsuit involving the ...
GSK said in a statement that it did not settle with the woman ... More than 72,000 lawsuits remain pending over Zantac against companies that sold the drug, which also includes Pfizer and Sanofi.
GSK’s shares fell sharply following a judge's decision to allow more than 70,000 lawsuits to proceed, alleging it’s Zantac ...
A settlement would ... Read More: GSK, Pfizer, Peers Zantac Legal Risk Rises by Billions on Ruling GSK is set to appeal the ruling, it said. The drugmaker emphasized that the decision “does not mean ...
The judge's decision, issued late Friday, permits expert witnesses to testify that Zantac may cause cancer. GSK, along with former Zantac manufacturers Pfizer, Sanofi (NASDAQ ... is seen as relatively ...
GSK results from a Phase 2 study that found Jemperli showed a 100% clinical complete response rate in patients with mismatch ...
GSK shares have plunged after a ruling by a Delaware judge that will force the company to face trial by jury for its Zantac ...
Along with GSK and Pfizer, Sanofi and Boehringer Ingelheim GmbH have been sued by consumers. After the federal cases were ...